2 Fundamental Reasons Why Bristol-Myers Squibb Is Outpacing Both Merck And …Seeking Alpha… SPRYCEL for treatment of chronic myeloid leukemia in adults; YERVOY to treat metastatic melanoma; ORENCIA to treat moderate to severe rheumatoid arthritis in…
Allentown Morning CallUpper Nazareth boy named a state champion after double lung transplantAllentown Morning CallTwo years after his double-lung transplant, acute rejection is no longer a threat, Maeding says. But now they must watch for chronic rejec…
Adjuvanted Influenza Vaccine Safe in Kidney Transplant RecipientsRenal and Urology NewsSAN FRANCISCO—The use of adjuvanted pandemic (H1N1) 2009 influenza vaccine appears to be safe in terms of risk for acute rejection and long-term graft outcome in k…
Sciences create 'living football' using cells from a pig's bladderThe EngineerGrowing bladders from small samples of the patients' own bladder tissue reduced the risk of transplant rejection. The Liverpool team followed a similar proced…
Family's love supports Chattanooga two-year-old in fight against kidney …Chattanooga Times Free PressThe first problem after transplant is dealing with acute rejection, but the longer the kidney stays in the body, the less likely rejection become…
Argos Therapeutics' immunotherapy technology receives US & EU patentspharmabiz.comThese candidates include AGS-003 to treat metastatic renal cell carcinoma, AGS-004 to treat HIV, AGS-009 to treat lupus, and AGS-010 to treat transplant rejection…
Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for …Sacramento Bee… R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 clinical trials; …
Doctor TipsterStatins May Inhibit Tumor Growth According To StudyDoctor TipsterThis findings are also useful in preventing transplant rejection, because it is known that immune cells which are mediating organ rejection are transported via lymphatic ves…
Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for …Equities.com… R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 clinical trials; an…
Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for …The Herald | HeraldOnline.com… R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 cl…